Ms. Blau brings 20 plus years of industry experience in bio-pharmaceutical research, development and manufacturing, including programs bringing new vaccines and natural protein-based pharmaceuticals to market. Ms. Blau has spent the last 7 years leading and developing capability within the manufacturing team at KeraNetics. In addition to producing keratin biomaterials for unique medical devices, she has been instrumental in implementing robust, cGMP-compliant quality systems, while driving systemic process improvements leading to throughput improvements and cost reduction. She holds a BA in Biological Sciences from University of Delaware.
Luke Burnett, PhD
Chief Executive Officer and Chief Science Officer
Dr. Burnett has extensive experience working with keratin biomaterials and supervises projects investigating their use in wound and burn healing, tissue engineering and regenerative medicine applications. Dr. Burnett has extensive leadership experience both in science, leading teams of industry and academic scientists on several NIH and DoD funded projects, and recently retired as a Colonel after serving 27 years in the US Army. Dr. Burnett holds a BS from Sonoma State University, a MA from the US Army War College, and a PhD from Wake Forest School of Medicine.
Ryan Clohessy, PhD
Dr. Clohessy has conducted biomaterials research for over six years and has been part of the KeraNetics team for more than two. With experience in in vitro and in vivo experimental design, he has led product and process development, as well as pre-clinical and clinical studies to evaluate safety and efficacy of burn and wound healing keratin products. Dr. Clohessy has also coordinated multiple regulatory submissions, ranging from initial Request for Designationsto traditional FDA approval pathways. Dr. Clohessy holds a BS from the University of Virginia and a PhD from Virginia Commonwealth University.
Director of Government Affairs
Mrs. Gabard has over ten years experience in project development and program management and over three years experience in projects related to keratin biomaterials. Mrs. Gabard has worked as an interventionist and study coordinator in human clinical trials, consulted for multi center clinical trials, and acted as a project manager for animal studies for regenerative and trauma medicine efforts. She has a broad leadership experience, including facilitating older adult behavior change groups and initiating multi-county governmental-based action committees. She holds a BA from Wake Forest University and an MS from University of North Carolina, Greensboro.
Mr. Herendeen has over six years of experience working with keratin biomaterials. Mr. Herendeen has worked in a wide range of positions throughout his career in biotech, from Bioprocessing Technician to Product Manager. He has also worked as a project manager, a supply chain manager, and consulted for cosmetic and OTC (GMP) manufacturers. He has extensive experience leading and participating in cross-functional teams for product and process development purposes. He holds a BA from the University of North Carolina at Chapel Hill and an MS from Wake Forest University.
Chris Holder, PhD
Director of Research and Development
Dr. Holder has spent over 18 years conducting biomedically-relevant scientific research, with more than 4 years of experience specifically devoted to keratin biomaterials and product development. He has participated in or supervised projects investigating burn and wound healing, bone regeneration, muscle regeneration, small molecule delivery, joint therapy, and bacterial pathogenesis. Dr. Holder has broad leadership experience, including laboratory management and teaching responsibilities in academic and biotechnology settings. He also has personnel management experience from his time as a Staff Sergeant in the United States Army Reserve. Dr. Holder holds a BS from Clemson University, an MS from the University of Maryland – College Park, and a PhD from the Wake Forest School of Medicine.
L. Andrew Koman, MD
Chief Medical Officer, Board Member
Dr. Koman is Professor and Chair of the Department of Orthopaedic Surgery at Wake Forest School of Medicine in Winston-Salem, North Carolina. After graduating from Duke University School of Medicine, his postgraduate training at Duke University included one year of Pediatrics, one year of General Surgery, four years of Orthopaedic Surgery and six months of Hand Surgery and Microsurgery. He served on the faculty at Duke for 18 months before joining the faculty at Wake Forest, where he remains.
Tracie Moreau, CPA
Vice President of Finance, Secretary, and Treasurer
Ms. Moreau brings over twenty years of business and accounting experience to this role. Ms. Moreau was previously in public accounting for over twenty years prior to joining KeraNetics. She is well versed in government accounting requirements and setups for government contractors as well as equity transactions particular to biotech companies. Ms. Moreau received a B.S. from High Point University and a MBA from Appalachian State University. She is a Certified Public Accountant.
Managing Director of Operations
Mr. Parker brings over 20 years of engineering and operational leadership experience in world-class consumer goods manufacturing companies, most of which was associated with FDA-regulated products. Mr. Parker has worked as a process engineer and as a Plant Manager for a large manufacturing facility, where he led a team of >750 employees. Dave later served as Chief Operating Officer for Ei, Inc., a specialty topical pharmaceutical manufacturer. He holds a BS and an MS from North Carolina State University.
Senior Director of Quality
Mrs. Williams has over 20 years of Quality experience including GMP and ISO in small and large companies, including Fortune 500 organizations. She has held several positions such as Quality Assurance Technician, Process Specialist, Calibration Coordinator, Standards Chemist, Lab Supervisor, and Quality Manager in processing facilities and a contract laboratory. In each of these previous roles, Chiquita implemented and practiced standards that optimized the quality of systems and products. As Senior Director of Quality, she is responsible for comprehensive quality as defined by assurance, control, and systems. She holds a BS in Chemistry from Longwood College.